These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15380963)

  • 1. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.
    Fernandez-Avilés F; Alonso JJ; Castro-Beiras A; Vázquez N; Blanco J; Alonso-Briales J; López-Mesa J; Fernández-Vazquez F; Calvo I; Martínez-Elbal L; San Román JA; Ramos B;
    Lancet; 2004 Sep 18-24; 364(9439):1045-53. PubMed ID: 15380963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial.
    Di Mario C; Dudek D; Piscione F; Mielecki W; Savonitto S; Murena E; Dimopoulos K; Manari A; Gaspardone A; Ochala A; Zmudka K; Bolognese L; Steg PG; Flather M;
    Lancet; 2008 Feb; 371(9612):559-68. PubMed ID: 18280326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial.
    Sabate M; Cequier A; Iñiguez A; Serra A; Hernandez-Antolin R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Gómez-Hospital JA; Baz JA; Martin-Yuste V; van Geuns RJ; Alfonso F; Bordes P; Tebaldi M; Masotti M; Silvestro A; Backx B; Brugaletta S; van Es GA; Serruys PW
    Lancet; 2012 Oct; 380(9852):1482-90. PubMed ID: 22951305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.
    Spacek R; Widimský P; Straka Z; Jiresová E; Dvorák J; Polásek R; Karel I; Jirmár R; Lisa L; Budesínský T; Málek F; Stanka P
    Eur Heart J; 2002 Feb; 23(3):230-8. PubMed ID: 11792138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
    Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
    Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.
    Fox KA; Poole-Wilson P; Clayton TC; Henderson RA; Shaw TR; Wheatley DJ; Knight R; Pocock SJ
    Lancet; 2005 Sep 10-16; 366(9489):914-20. PubMed ID: 16154018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial.
    Fernández-Avilés F; Alonso JJ; Peña G; Blanco J; Alonso-Briales J; López-Mesa J; Fernández-Vázquez F; Moreu J; Hernández RA; Castro-Beiras A; Gabriel R; Gibson CM; Sánchez PL;
    Eur Heart J; 2007 Apr; 28(8):949-60. PubMed ID: 17244641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study).
    Le May MR; Wells GA; Labinaz M; Davies RF; Turek M; Leddy D; Maloney J; McKibbin T; Quinn B; Beanlands RS; Glover C; Marquis JF; O'Brien ER; Williams WL; Higginson LA
    J Am Coll Cardiol; 2005 Aug; 46(3):417-24. PubMed ID: 16053952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.
    D'Souza SP; Mamas MA; Fraser DG; Fath-Ordoubadi F
    Eur Heart J; 2011 Apr; 32(8):972-82. PubMed ID: 21036776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early routine angioplasty versus selective angioplasty after successful thrombolysis in acute ST-segment elevation myocardial infarction.
    Geng W; Tian X; Fu X; Wang P; Wang Y; Wang X; Li W; Liu X
    Coron Artery Dis; 2013 May; 24(3):238-43. PubMed ID: 23358446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.
    Vlaar PJ; Svilaas T; van der Horst IC; Diercks GF; Fokkema ML; de Smet BJ; van den Heuvel AF; Anthonio RL; Jessurun GA; Tan ES; Suurmeijer AJ; Zijlstra F
    Lancet; 2008 Jun; 371(9628):1915-20. PubMed ID: 18539223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial.
    Sutton AG; Campbell PG; Graham R; Price DJ; Gray JC; Grech ED; Hall JA; Harcombe AA; Wright RA; Smith RH; Murphy JJ; Shyam-Sundar A; Stewart MJ; Davies A; Linker NJ; de Belder MA
    J Am Coll Cardiol; 2004 Jul; 44(2):287-96. PubMed ID: 15261920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery disease.
    Elbarouni B; Cantor WJ; Ducas J; Borgundvaag B; Džavík V; Heffernan M; Buller CE; Langer A; Goodman SG; Yan AT;
    Can J Cardiol; 2014 Dec; 30(12):1555-61. PubMed ID: 25475460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
    Tegn N; Abdelnoor M; Aaberge L; Endresen K; Smith P; Aakhus S; Gjertsen E; Dahl-Hofseth O; Ranhoff AH; Gullestad L; Bendz B;
    Lancet; 2016 Mar; 387(10023):1057-1065. PubMed ID: 26794722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial.
    Sutton AG; Campbell PG; Graham R; Price DJ; Gray JC; Grech ED; Hall JA; Harcombe AA; Wright RA; Smith RH; Murphy JJ; Shyam-Sundar A; Stewart MJ; Davies A; Linker NJ; de Belder MA
    Heart; 2005 Oct; 91(10):1330-7. PubMed ID: 16162629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early invasive versus conservative treatment in patients with failed fibrinolysis--no late survival benefit: the final analysis of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) randomized trial.
    Kunadian B; Sutton AG; Vijayalakshmi K; Thornley AR; Gray JC; Grech ED; Hall JA; Harcombe AA; Wright RA; Smith RH; Murphy JJ; Shyam-Sundar A; Stewart MJ; Davies A; Linker NJ; de Belder MA
    Am Heart J; 2007 May; 153(5):763-71. PubMed ID: 17452151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.